Dr. Mila T. Riehl, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2215 Mallard Ln Se, Decatur, AL 35601 Phone: 256-476-4118 |
Dr. Lloyd James, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1201 7th St Se, Decatur, AL 35601 Phone: 256-341-2909 Fax: 256-341-2552 |
Dr. Tom-meka Michele Archinard, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1201 7th St Se, Decatur Morgan Hospital, Decatur, AL 35601 Phone: 256-973-2000 |
Dewight Cowley Jr., M.D., MPH Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1201 7th St Se, Decatur, AL 35601 Phone: 256-973-3328 |
Roger H Moss Jr., MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1201 Somerville Rd Se, Decatur, AL 35601 Phone: 256-350-0909 Fax: 256-355-1528 |
Dr. William Larry Sullivan, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 4308 Topaz Cir Se, Decatur, AL 35603 Phone: 256-686-1222 |
Dr. Gene Edward Walker Jr., M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1201 7th St Se, Decatur, AL 35601 Phone: 256-973-2000 |
Mr. Allen James Schmidt Jr., MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1501 7th St Se, Decatur, AL 35601 Phone: 256-350-2210 Fax: 256-350-2735 |
Dr. John Peter Kaliszak, MD Emergency Medicine Medicare: May Accept Medicare Assignments Practice Location: 1201 7th St Se, Decatur, AL 35601 Phone: 256-341-2175 Fax: 256-641-2675 |
Dr. Steven C Hodges, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1201 7th St Se, Decatur, AL 35601 Phone: 256-341-2175 Fax: 256-341-2675 |
News Archive
Previously linked to the severity of asthma and chronic obstructive pulmonary disease in humans, vitamin D deficiency has now been shown to alter lung structure and function in young mice. The new study, conducted by researchers in Australia, offers the first concrete evidence linking vitamin D deficiency with deficits in lung function and altered lung structure.
Alvine Pharmaceuticals, Inc. today announced the presentation of data from a Phase 2A trial of its lead compound, ALV003, at the 2012 Digestive Diseases Week (DDW) meeting held in San Diego, California. The study results met the primary endpoint of demonstrating that oral ALV003, administered in the context of a gluten free diet (GFD), can diminish gluten-induced intestinal mucosal injury in well-controlled celiac disease patients. The company plans to initiate a Phase 2B trial later this year.
Health and Human Services Secretary Kathleen Sebelius announced today that states and local organizations can apply for $40 million worth of outreach grants "to enroll more eligible children in health-insurance programs," according to the Wall Street Journal.
Ludwig Cancer Research scientists have developed a new and more accurate method to identify the molecular signs of cancer likely to be presented to helper T cells, which stimulate and orchestrate the immune response to tumors and infectious agents.
› Verified 2 days ago